Combination lipid-lowering therapy as first-line strategy in very high-risk patients

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

Kausik K. Ray, Bart Molemans, W. Marieke Schoonen et al. · European Journal of Preventive Cardiology · 2020 · 767 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke

Pierre Amarenco, Julien Labreuche, Yannick Béjot et al. · New England Journal of Medicine · 2019 · 565 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both

Brian A. Ference, Faisal Majeed, Raju Penumetcha et al. · Journal of the American College of Cardiology · 2015 · 431 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

An International Model to Predict Recurrent Cardiovascular Disease

Peter W.F. Wilson, Ralph B. D’Agostino, Deepak L. Bhatt et al. · The American Journal of Medicine · 2012 · 245 citations · Full text

Medicine, Cardiology, Clinical Cardiology +11